U.S. Urges India To Impose Strict Laws Against Counterfeit Drugs
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Office of the United States Trade Representative has taken a strong stand against counterfeit drugs in India, placing the country on the USTR priority watch list and calling for better and effective systems to check counterfeit drugs